PT-141, also known as Bremelanotide, is a synthetic peptide from the melanocortin agonist group, developed as an analogue of -MSH (-Melanocyte-Stimulating Hormone)
Leading Healthcare Innovation Accessing verified, high-purity peptide and research chemicals shouldnt be complicated
And it is possible that factors not accounted for, such as socioeconomic status or lifestyle, may have affected the results
Similarly, without these outcomes, 40% plan to start and stop based on needs, compared to 22% with no side effects
Therefore, increased ATP levels by ATP regulators may provide a strategy for cell/tissue protection in LC as reported in neurological condition (69)